Skip to Main Content
Skip Nav Destination

Optimal Timing and Dosing Intervals of Palivizumab in Premature Neonates: Still Some Work to Do: In Reply

Pediatrics (2005) 115 (5): 1440–1441.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Current Opinion in Allergy & Clinical Immunology (2006) 6 (1): 67.
Close Modal

or Create an Account

Close Modal
Close Modal